Precision Engineered Cell Mimics for Flow Cytometry

Hits:44   Date: 8/19/2026

Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls.
 
Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long term for the development of targeted therapies.

Precision-engineered cell mimics

 
Benefitting from unmatched lot-to-lot consistency with coefficients of variation as low as 0.1% these new synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments. This consistency is a critical requirement for clinical trials, cell therapy manufacturing, and rapid, successful regulatory submissions.
 
For laboratory teams running flow cytometry assays across instruments, operators, and sites, Amsbio can now offer cell-mimic controls that deliver biology-like behaviour without donor PBMCs’ variability, biohazardous materials safety burden, or cell lines maintenance overhead. This helps researchers standardize workflows, tighten assay performance, and reduce bridging studies. Offering extended shelf life with no maintenance required – synthetic cell mimics from Amsbio are fully customizable with biomarkers, proteins, and fluorescence making them perfect for any need.
 
To learn more about how synthetic cell mimics can improve your flow cytometry cell-based assays please visit https://www.amsbio.com/suppliers/slingshotbio/ or contact Amsbio on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.
 
Amsbio, part of the Europa Biosite group, is a leading life sciences company supporting drug discovery, translational research, and cell and gene therapy across Europe, North America, and wider international markets. With in depth expertise in advanced cell culture, 3D cell models, and cryopreservation, Amsbio is well placed to help researchers progress from early discovery through to clinical and GMP-ready applications. The company’s portfolio of innovative products and services supports multiple stages of the research pipeline, spanning target discovery, assay development, and disease modelling, through to stem cell and organoid-based research. Key solutions include the integrated stem call platform combining StemFit™ media, iMatrix™ recombinant laminins, and CELLBANKER™ cryopreservation technology, alongside extracellular matrix technologies, biospecimens, glycobiology tools, kits and assays, and a wide range of custom services including viral delivery. Drawing on extensive GMP expertise and a comprehensive human and animal biorepository, Amsbio is internationally recognized for delivering high-quality, application-ready products and services. Amsbio has a consistent record of close scientific collaboration with partners in academic, biotech, and pharmaceutical markets to translate innovation from bench to bedside.
 
---------------------

Worldwide HQ

AMS Biotechnology Europe Ltd (Amsbio)
2-3, Munro House
Trafalgar Way
Bar Hill
Cambridge, CB23 8SQ
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web: www.amsbio.com
 
North American HQ
Amsbio LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web: www.amsbio.com